Recombinant human antithrombin inhibits thrombin formation and interleukin 6 release in human endotoxemia.

Leitner, Judith M

Recombinant human antithrombin inhibits thrombin formation and interleukin 6 release in human endotoxemia. [electronic resource] - Clinical pharmacology and therapeutics Jan 2006 - 23-34 p. digital

Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

0009-9236

10.1016/j.clpt.2005.10.003 doi


Adult
Anticoagulants
Antithrombins--pharmacokinetics
Biomarkers
Blood Coagulation--drug effects
Dose-Response Relationship, Drug
Double-Blind Method
Endotoxemia--chemically induced
Fibrinolysis--drug effects
Hemodynamics--drug effects
Humans
In Vitro Techniques
Inflammation Mediators--blood
Interleukin-6--metabolism
Leukocyte Count
Lipopolysaccharides--pharmacology
Male
Partial Thromboplastin Time
Peptide Fragments--analysis
Prothrombin--analysis
Prothrombin Time
RNA, Messenger--biosynthesis
Recombinant Proteins--pharmacokinetics
Thrombelastography
Thrombin--biosynthesis